Viemed Healthcare, Inc. (VMD)

Viemed Healthcare Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	232.79	224.26	183.01	138.83	117.06	131.31
Revenue Growth (YoY)	19.97%	22.54%	31.82%	18.60%	-10.85%	63.61%
Cost of Revenue	96.11	91.05	70.23	54.15	43.65	51.2
Gross Profit	136.68	133.2	112.78	84.68	73.41	80.11
Selling, General & Admin	109.48	105.85	87.35	68.16	54.89	52.83
Research & Development	3.12	3.07	2.78	2.7	2.11	1.08
Other Operating Expenses	-0.78	-0.73	-0.1	-0.79	-0.12	-0.45
Operating Expenses	120.4	115.95	97.27	76.28	62.88	59.16
Operating Income	16.28	17.25	15.51	8.4	10.53	20.95
Interest Expense	-0.81	-0.78	-0.42	-0.2	-0.32	-0.51
Interest & Investment Income	-	-	0.49	0.94	-	-
Earnings From Equity Investments	-0.07	-	-	-	1.24	0.09
EBT Excluding Unusual Items	15.41	16.47	15.57	9.14	11.45	20.54
Merger & Restructuring Charges	-0.33	-0.35	-0.54	-	-	-
Gain (Loss) on Sale of Investments	-0.95	-0.95	-	-	-	-
Gain (Loss) on Sale of Assets	4.49	1.91	-0.65	-0.35	-0.45	2.33
Other Unusual Items	-0.9	-0.9	-	0.2	1.5	3.5
Pretax Income	17.71	16.17	14.39	8.99	12.5	26.36
Income Tax Expense	5.2	4.76	4.15	2.77	3.38	-5.17
Earnings From Continuing Operations	12.52	11.41	10.24	6.22	9.13	31.53
Minority Interest in Earnings	-0.23	-0.14	-	-	-	-
Net Income	12.29	11.27	10.24	6.22	9.13	31.53
Net Income to Common	12.29	11.27	10.24	6.22	9.13	31.53
Net Income Growth	18.96%	9.98%	64.63%	-31.82%	-71.06%	269.85%
Shares Outstanding (Basic)	39	39	38	39	39	39
Shares Outstanding (Diluted)	41	41	40	40	41	41
Shares Change (YoY)	1.35%	1.05%	1.44%	-2.15%	0.38%	1.96%
EPS (Basic)	0.32	0.29	0.27	0.16	0.23	0.81
EPS (Diluted)	0.30	0.28	0.25	0.16	0.22	0.78
EPS Growth	19.95%	12.00%	56.25%	-27.27%	-71.80%	271.43%
Free Cash Flow	-6.48	1.32	19.12	4.85	2.75	22.07
Free Cash Flow Per Share	-0.16	0.03	0.47	0.12	0.07	0.54
Gross Margin	58.71%	59.40%	61.63%	60.99%	62.71%	61.01%
Operating Margin	6.99%	7.69%	8.48%	6.05%	8.99%	15.96%
Profit Margin	5.28%	5.02%	5.60%	4.48%	7.80%	24.01%
Free Cash Flow Margin	-2.78%	0.59%	10.45%	3.49%	2.35%	16.80%
EBITDA	41.98	42.62	37.38	24.03	21.84	30.54
EBITDA Margin	18.03%	19.00%	20.42%	17.31%	18.66%	23.25%
D&A For EBITDA	25.7	25.37	21.86	15.63	11.31	9.58
EBIT	16.28	17.25	15.51	8.4	10.53	20.95
EBIT Margin	6.99%	7.69%	8.48%	6.05%	8.99%	15.96%
Effective Tax Rate	29.33%	29.44%	28.82%	30.79%	27.01%	-

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q